Loading viewer...
earnings
Format: PDF earnings
Ambu's Q1 2013/2014 interim report covering the period October 1 to December 31, 2013, shows 27% revenue increase with 4% underlying organic growth. The report highlights strong market acceptance of aScope 3, improving gross margins from synergies, and reduced net working capital while maintaining full-year guidance.
investor_presentation
13 Pages
earnings
28 Pages
Endo International
Applied Optoelectronics Q2 2024 Investor Presentation
earningsearnings
30 Pages
Applied Optoelectronics
Nova Eye Medical FY2023 Annual Results – ASX:EYE
earningsearnings
15 Pages
Nova Eye Medical Limited
Santander Consumer USA 2016 Earnings Fourth Quarter Full Year Results
earningsearnings
33 Pages
Santander Consumer USA Holdings